期刊文献+

患者报告结局在食管癌外科领域的研究现状 被引量:3

Research status of patient-reported outcome in esophageal carcinoma surgery
原文传递
导出
摘要 食管癌是全球范围内发病率和致死率均较高的恶性肿瘤,外科手术是其主要的治疗方式。随着“以患者为中心”的医学服务理念的不断深入,食管癌手术患者的治疗效果不应仅局限于术后并发症发生率和死亡率等指标的改善,从患者的角度出发提供疾病及手术相关的各类体验也尤为重要,患者报告结局正是基于此原因受到了越来越多的关注和研究。本文将对国际上应用广泛、可靠性和有效性较高的评估量表及患者报告结局在食管癌外科领域的应用研究现状进行综述。 Esophageal carcinoma is a malignant tumor with high morbidity and mortality worldwide,and surgery is the main treatment currently.With the development of patient-centered care,the effect of surgery should not be limited to the improvement of the incidence of postoperative complications,mortality and other indicators.It is also important to provide experience related to disease and surgery from the perspective of patients.Therefore,more and more attention is paid to patient-reported outcomes by scholars.This paper will provide an overview of the international widely used,reliable and effective scales and researches about patient-reported outcomes in esophageal carcinoma.
作者 林琳 郑娥 杨梅 袁勇 车国卫 宁宁 LIN Lin;ZHENG E;YANG Mei;YUAN Yong;CHE Guowei;NING Ning(West China School of Nursing,Sichuan University/Department of Thoracic Surgery,West China Hospital,Sichuan University,Chengdu,610041,P.R.China;Department of Thoracic Surgery,West China Hospital,Sichuan University,Chengdu,610041,P.R.China;West China School of Nursing,Sichuan University/Department of Orthopedics,West China Hospital,Sichuan University,Chengdu,610041,P.R.China)
出处 《中国胸心血管外科临床杂志》 CSCD 北大核心 2022年第12期1660-1664,共5页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 国家自然科学基金(81970481)。
关键词 食管癌 患者报告结局 研究现状 综述 Esophageal carcinoma patient-reported outcomes research status review
  • 相关文献

参考文献9

二级参考文献68

  • 1苏义,周凌明,徐幻,张萌,易学明.医院人力资源链式管理实践[J].医学研究生学报,2011,24(7):752-753. 被引量:20
  • 2李学民,汤萨,彭秀青,黄佳,王伟鹏,张朋,赵学科,宋昕,王苒,范宗民,雷晓雨,王立东.1973—2005年手术治疗食管癌患者5年生存率变化分析[J].肿瘤防治研究,2014,41(3):237-242. 被引量:30
  • 3万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1318
  • 4刘保延.有关辨证论治临床评价若干问题的思考[J].中医杂志,2007,48(1):12-14. 被引量:55
  • 5杜洪飞.经典测量理论与项目反应理论的比较研究[J].社会心理科学,2006,21(6):15-17. 被引量:16
  • 6U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Re- search, U.S. Department of Health and Human Services FDA Cen- ter for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product devel- opment to support labeling claims: draft guidance [J]. Health Qual Life Outcomes, 2006, 4: 79.
  • 7Acquadro C, Berzon R, Dubois D, et al. Incorporating the pa- tient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administra- tion, February 16, 2001 [J]. Value Health, 2001, 6 (5): 522-531.
  • 8Fiscella K, Ransom S, Jean-Pierre P, et al. Patient-reported outcome measures suitable to assessment of patient navigation [J]. Cancer, 2011, 117 (15Suppl): 3603-3617.
  • 9Sloan JA, Halyard MY, Frost MH, et al. The Mayo clinic manuscript series relative to the discussion, dissemination, and operationalization of the food and drug administration guidance on patient-reported outcomes [J]. Value Health, 2007, 10 Suppl 2 (supple2) : S59-S63.
  • 10Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues [J]. Value Health, 2004, 7 (2): 204-215.

共引文献141

同被引文献38

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部